KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationLeasesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

AbCellera Biologics (ABCL) Preferred Shares Issued (2020)

AbCellera Biologics (ABCL) has disclosed Preferred Shares Issued for 1 consecutive years, with -$1000.0 as the latest value for Q4 2020.

  • For the quarter ending Q4 2020, Preferred Shares Issued changed N/A year-over-year to -$1000.0, compared with a TTM value of $74.7 million through Dec 2020, changed N/A, and an annual FY2020 reading of $74.7 million, up 678845.45% over the prior year.
  • Preferred Shares Issued was -$1000.0 for Q4 2020 at AbCellera Biologics, up from -$19000.0 in the prior quarter.
  • Across five years, Preferred Shares Issued topped out at $74.7 million in Q1 2020 and bottomed at -$19000.0 in Q3 2020.